E-ISSN 2148-5607
RELATED ARTICLES
Editorial
Serum digoxin-like immunoreactive substances in chronic liver disease
(Turk J Gastroenterol 1997; 8: 283-285)
histological outcome after interferon therapy in chronic viral hepatitis
(Turk J Gastroenterol 1997; 8: 291-294)
Is there any relationship between Behçet's disease and hepatit C virus?
(Turk J Gastroenterol 1998; 9: 10-13)
Delta infection among children with cronic viral hepatitis
(Turk J Gastroenterol 1998; 9: 21-23)
Effects of Giardia lamblia infestation on the clinical sourse of cronic hepatitis B
(Turk J Gastroenterol 1998; 9: 24-27)
Frequency of HBsAg/anti-HCV seropositivity and its relationship with risk factors in extrahepatic malignancies
(Turk J Gastroenterol 1998; 9: 28-31)
Acute rubeola hepatitis
(Turk J Gastroenterol 1998; 9: 66-69)
Acral erythema induced bu interferon alpha in a child
(Turk J Gastroenterol 1998; 9: 70-72)
Hepatitis C infection in non-Hodgkin's lymphoma
(Turk J Gastroenterol 1998; 9: 73-75)
Hepatitis C virus and deep abdominal lymphadenopathy
(Turk J Gastroenterol 1998; 9: 91-94)
Effect of anti-HCV positifity on response to hepatitis B virus vaccine in haemodialysis patients
(Turk J Gastroenterol 1998; 9: 105-107)
Etiologies of chronic hepatitis
(Turk J Gastroenterol 1998; 9: 113-115)
Apoptosis in selected liver diseases
(Turk J Gastroenterol 2009; 20: 171-179)
DOI: 10.4318/tjg.2009.0003
The quality of life in hemodialysis patients with chronic hepatitis C virus infection
(Turk J Gastroenterol 2009; 20: 243-246)
DOI: 10.4318/tjg.2009.0020
Prevelance and genotyping of hepatitis C virus RNA in Turkish patinets with non-A, non-B liver disease
(Turk J Gastroenterol 1998; 9: 208-212)
The prevalence of hepatocellular carcinoma in patients with liver cirrhosis in Southeastern Turkey
(Turk J Gastroenterol 1998; 9: 217-220)
Human tissue transglutaminase antibody screening by immunochromatographic line immunoassay for early diagnosis of celiac disease in Turkish children
(Turk J Gastroenterol 2008; 19: 14-21)
Lamivudine resistance in untreated chronic hepatitis B patients in Turkey
(Turk J Gastroenterol 2008; 19: 99-103)
Prevalence and clinical significance of SEN-H virus in chronic hepatitis B, C and delta infections in Turkey
(Turk J Gastroenterol 2008; 19: 104-108)
Alterations in serum levels of the natural anticoagulants in chronic liver disease and their relations to portal thrombosis
(Turk J Gastroenterol 1998; 9: 313-316)
Is there any correlation between anti-HBc IgM index and HBV DNA level in patients with chroin hepatitis B?
(Turk J Gastroenterol 1998; 9: 317-319)
Low prevalence of erosive esophagitis and Barrett esophagus in a tertiary referral center in Turkey
(Turk J Gastroenterol 2008; 19: 146-151)
Overlap of symptoms of dyspepsia and gastroesophageal reflux in the community
(Turk J Gastroenterol 2007; 18: 14-19)
Seroprevalence of anti-Helicobacter pylori and anti-CagA antibodies among healthy children according to age, sex, ABO blood groups and Rh status in south-east of Iran
(Turk J Gastroenterol 2007; 18: 165-171)
Transient sinus bradycardia in a child during the course of acute hepatitis A
(Turk J Gastroenterol 2007; 18: 195-197)
Association between type 2 diabetes mellitus and Helicobacter pylori infection
(Turk J Gastroenterol 2007; 18: 225-229)
Pegylated interferon treatment of acute pericarditis associated with acute hepatitis C
(Turk J Gastroenterol 2007; 18: 268-271)
The prevalence of hepatitis delta virus infection in acute and chronic liver diseases in Turkey: An analysis of clinical studies
(Turk J Gastroenterol 2006; 17: 25-34)
Daily consensus interferon (CIFN) monotherapy in non-responders or relapsers to a previous interferon regime: One year follow-up after 48 weeks of treatment
(Turk J Gastroenterol 2006; 17: 35-39)
The efficacy of pegylated interferon alpha 2a or 2b plus ribavirin in chronic hepatitis C patients
(Turk J Gastroenterol 2006; 17: 79-83)
The efficacy of pegylated interferon alpha 2a or 2b plus ribavirin in chronic hepatitis C patients
(Turk J Gastroenterol 2006; 17: 94-98)
Hepatitis A and parvovirus B19 infections in an infant with fulminant hepatic failure
(Turk J Gastroenterol 2006; 17: 148-150)
Change in plasma concentrations of lipid peroxidation products in patients with acute viral hepatitis
(Turk J Gastroenterol 1999; 10: 4-6)
The value of ultrasonography in the diagnosis of early cirrhosis*
(Turk J Gastroenterol 1999; 10: 7-10)
An asymptomatic huge hepatocellular carcinoma with intra-atrial tumor thrombus in a patient with chronic hepatitis B viral infection
(Turk J Gastroenterol 2006; 17: 203-205)
Assessment of bone metabolism and mineral density in chronic viral hepatitis
(Turk J Gastroenterol 2006; 17: 260-266)
Hepatitis B and C virus in West-Central Turkey: Seroprevalence in healthy individuals admitted to a university hospital for routine health checks
(Turk J Gastroenterol 2006; 17: 267-272)
P21 expression and its relation to disease activity and hepatocyte proliferation in chronic hepatitis B virus infection
(Turk J Gastroenterol 2005; 16: 12-16)
The coexistence of hepatitis A and infectious mononucleosis
(Turk J Gastroenterol 2005; 16: 102-104)
A new marker for lipid peroxidation: Serum paraoxonase activity in non-alcoholic steatohepatitis
(Turk J Gastroenterol 2005; 16: 119-123)
Management of fatty liver disease with vitamin E and C compared to ursodeoxycholic acid treatment
(Turk J Gastroenterol 2005; 16: 124-128)
Importance of anticoagulant proteins in chronic liver diseases
(Turk J Gastroenterol 2005; 16: 129-133)
Determination of hepatitis B genotypes in patients with chronic hepatitis B virus infection in Turkey
(Turk J Gastroenterol 2005; 16: 183-187)
Immunomodulatory effects of HBsAg vaccine and levamisole in chronic hepatitis B and hepatitis B carrier children
(Turk J Gastroenterol 2005; 16: 188-193)
Anadoluda anne ve bebeklerinde Helikobakter pilori enfeksiyonu
(Turk J Gastroenterol 2010; 21: 113-118)
DOI: 10.4318/tjg.2010.0067
Seroepidemiology of delta hepatitis in Turkey
(Turk J Gastroenterol 1999; 10: 316-327)
Daily use of consensus interferon: One-year treatment results for chronic hepatitis C patients relapsing ornon-responding to previous interferon
(Turk J Gastroenterol 2000; 11: 191-195)
L-Carnitine therapy in non-alcoholic steatohepatitis
(Turk J Gastroenterol 2000; 11: 196-201)
Effect of interferon treatment on glucose metabolism in children with chronic hepatitis B infection
(Turk J Gastroenterol 2004; 15: 4-10)
Hepatitis B carriage and Brucella seroprevalence in urban and rural areas of Bolu province of Turkey: A prospective epidemiologic study
(Turk J Gastroenterol 2004; 15: 11-13)
A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels
(Turk J Gastroenterol 2004; 15: 14-20)
Lichen planus and HCV infection in Turkish patients
(Turk J Gastroenterol 2004; 15: 133-136)
*Changes in the seroepidemiological pattern of Helicobacter pylori infection over the last 10 years in Turkey
(Turk J Gastroenterol 2004; 15: 156-158)
Celiac disease in patients having recurrent aphthous stomatitis
(Turk J Gastroenterol 2004; 15: 192-195)
Autoantibodies in children with chronic hepatitis B infection and the influence of interferon alpha
(Turk J Gastroenterol 2004; 15: 213-218)
Predictive value of proliferating cell nuclear antigen index in response to interferon treatment in patients with chronic viral hepatitis B and C
(Turk J Gastroenterol 2001; 12: 89-94)
Ursodeoxycholic acid can be used as a steroid-tapering drug in the treatment of autoimmune hepatitis
(Turk J Gastroenterol 2001; 12: 249-252)
Prolonged jaundice, azotomia and leucopenia in a patient with acute type B virus hepatitis
(Turk J Gastroenterol 1996; 7: 86-89)
A case of terbinafine associated hepatic injury
(Turk J Gastroenterol 1996; 7: 90-92)
Chronic hepatitis C with mixed cryoglubulinemia: A cade report
(Turk J Gastroenterol 1996; 7: 254-256)
Glucose intolerance in chronic C hepatitis patients in turkey
(Turk J Gastroenterol 1996; 7: 289-292)
Clinicopathologic features and risk factors for hepatocellular carcinoma: Results from a single center in southern Turkey
(Turk J Gastroenterol 2003; 14: 85-90)
Irritable bowel syndrome prevalence in city center of Sivas
(Turk J Gastroenterol 2003; 14: 128-131)
Spontaneous bacterial peritonitis due to Brucella infection
(Turk J Gastroenterol 2003; 14: 145-147)
Determination of serum hepatitis B virus DNA in chronic HBsAg carriers: Clinical significance and correlation with serological markers
(Turk J Gastroenterol 2003; 14: 157-163)
The use of tissue polypeptide specific antigen as a marker in liver diseases
(Turk J Gastroenterol 2003; 14: 177-180)
Type 1 gastric carcinoid tumor: another extrahepatic manifestation of hepatitis C virus infection?
(Turk J Gastroenterol 2003; 14: 194-196)
A case of autoimmune hepatitis and autoimmune hemolytic anemia following hepatitis A infection
(Turk J Gastroenterol 2003; 14: 204-207)
Nimesulide-induced fulminant hepatitis
(Turk J Gastroenterol 2003; 14: 208-210)
The importance of iron and copper accumulation in the pathogenesis of non-alcoholic steatohepatitis
(Turk J Gastroenterol 2003; 14: 228-233)
A comparative immunohistochemical study of HBsAg, HBcAg and CD57 in chronic hepatitis B pediatric patients with and without malignant disorders
(Turk J Gastroenterol 2003; 14: 234-238)
Hepatitis B seroprevalance and risk factors in urban areas of Malatya
(Turk J Gastroenterol 2002; 13: 1-5)
The effect of recombinant hepatitis B vaccine therapy in chronic hepatitis B infection
(Turk J Gastroenterol 2002; 13: 6-10)
Alanine aminotransferase deficiency in a hepatitis B surface antigen positive patient presenting with acute hepatitis
(Turk J Gastroenterol 2002; 13: 60-62)
Obesity and related parameters of non-alcoholic steatohepatitis
(Turk J Gastroenterol 2002; 13: 71-77)
Acute oligo-anuric renal failure during the course of non-fulminant hepatitis A in a patient with anorexia nervosa
(Turk J Gastroenterol 2002; 13: 164-167)
Serum levels of acute phase proteins in patients with nonalcoholic steatohepatitis
(Turk J Gastroenterol 2003; 14: 12-17)
Evaluation of the outcome of interferon therapy in chronic hepatitis B infection
(Turk J Gastroenterol 1999; 10: -)
Autoantibodies in chronic viral hepatitis and autoimmune hepatitis
(Turk J Gastroenterol 1997; 8: 381-384)
Importance of second and third generation ELISA test in detection of HVC antibody
(Turk J Gastroenterol 1997; 8: 144-147)
Response to hepatitis B vaccine in patients with non-hepatitis B chronic liver disease
(Turk J Gastroenterol 1997; 8: 148-151)
Seroprevalence of hepatitis B and C viruses in the province of Tokat in the Black Sea region of Turkey: A population-based study
(Turk J Gastroenterol 2009; 20: 27-30)
Transmission routes of chronic hepatitis C and their relation to HCV genotypes
(Turk J Gastroenterol 2010; 21: 396-400)
DOI: 10.4318/tjg.2010.0126
Determination of intracellular Th1/Th2 type cytokines in lymphocytes of chronic hepatitis B patients treated with interferon-alpha
(Turk J Gastroenterol 2010; 21: 401-410)
DOI: 10.4318/tjg.2010.0127
Gallstones associated with nonalcoholic steatohepatitis (NASH) and metabolic syndrome
(Turk J Gastroenterol 2010; 21: 411-415)
DOI: 10.4318/tjg.2010.0128
Fulminant hepatic failure related to Wilson’s disease
(Turk J Gastroenterol 1999; 10: 227-231)
Detection of HEV antibody seroprevalance in HAV antibody positive subjects
(Turk J Gastroenterol 1999; 10: 232-235)
Prevalence of cholelithiasis in a Turkish population sample of postmenopausal women
(Turk J Gastroenterol 2010; 21: 416-420)
DOI: 10.4318/tjg.2010.0129
Relationship between serum levels of interleukin-10, interleukin-2 and soluble intercellular adhesion molecule-I and liver injury in chronic hepatitis B virus infection
(Turk J Gastroenterol 1999; 10: 243-248)
HCV genotypes in HCV related chronic hepatitis in Southeast Anatolia
(Turk J Gastroenterol 1999; 10: 249-252)
Giant cell hepatitis and autoimmune hemolytic anemia after chickenpox
(Turk J Gastroenterol 2010; 21: 448-451)
DOI: 10.4318/tjg.2010.0135
Review
Apoptosis and fibrosis in non-alcoholic fatty liver disease
(Turk J Gastroenterol 2005; 16: 1-6)
Show Me Echo – Hepatitis C: A telemedicine mentoring program for patients with hepatitis C in underserved and rural areas in Missouri as a model in developing countries
(Turk J Gastroenterol 2015; 26: 447-449)
DOI: 10.5152/tjg.2015.159000
Nonalcoholic fatty liver disease: Diagnosis, pathogenesis, and management
(Turk J Gastroenterol 2014; 25: 127-132)
DOI: 10.5152/tjg.2014.7675
Emerging therapeutics and relevant targets for chronic Hepatitis B
(Turk J Gastroenterol 2016; 27: 210-215)
DOI: 10.5152/tjg.2016.15521
Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus report
(Turk J Gastroenterol 2018; 29: 259-269)
DOI: 10.5152/tjg.2018.18263
New modalities in the treatment of HCV in pre and post - transplantation setting
(Turk J Gastroenterol 2015; 26: 204-213)
DOI: 10.5152/tjg.2015.0204
Case Report
Recurrent bleeding of parastomal varices: Case report
(Turk J Gastroenterol 2011; 22: 329-332)
DOI: 10.4318/tjg.2011.0221
Severe aplastic anemia following liver transplantation in a patient with non-A-E fulminant hepatitis
(Turk J Gastroenterol 2011; 22: 337-340)
DOI: 10.4318/tjg.2011.0222
A case of gynecomastia due to entecavir
(Turk J Gastroenterol 2010; 21: 313-316)
DOI: 10.4318/tjg.2010.0108
Immune thrombocytopenic purpura as sole manifestation in a case of acute hepatitis A
(Turk J Gastroenterol 2005; 16: 217-219)
A case of herpes simplex hepatitis with hepatic nodules in an immunocompetent patient
(Turk J Gastroenterol 2007; 18: 115-118)
Acute hepatitis induced by Epstein- Barr virus infection: A case report
(Turk J Gastroenterol 2007; 18: 119-121)
Fascioliasis: 3 cases with three different clinical presentations
(Turk J Gastroenterol 2012; 23: 267-271)
DOI: 10.4318/tjg.2012.0388
Cyclosporine rescue therapy in autoimmune liver cirrhosis: A case report
(Turk J Gastroenterol 2012; 23: 599-603)
DOI: 10.4318/tjg.2012.0438
Icterohaemorrhagic leptospirosis in patients with history of alcohol abuse – report of two cases
(Turk J Gastroenterol 2013; 24: 549-555)
DOI: 10.4318/tjg.2013.0588
A case of entecavir resistance which is developed after complete viral suppression during entecavir treatment for nucleoside-naive chronic hepatitis B
(Turk J Gastroenterol 2014; 25: 206-209)
DOI: 10.5152/tjg.2014.3605
A case of entecavir-associated bullous fixed drug eruption and a review of literature
(Turk J Gastroenterol 2019; 30: 299-302)
DOI: 10.5152/tjg.2018.17887
Gastric cancer after cadaveric liver transplantation in a patient with autoimmune hepatitis: A case report and review of the literature
(Turk J Gastroenterol 2011; 22: 73-76)
DOI: 10.4318/tjg.2011.0160
Original Article
The prevalence of celiac disease in children with iron-deficiency anemia
(Turk J Gastroenterol 2013; 24: 334-338)
DOI: 10.4318/tjg.2013.0529
Prevelance of hepatitis D co-enfection in children with hepatitis B infection: Cross-sectional analyses from Western Turkey
(Turk J Gastroenterol 2013; 24: 345-348)
DOI: 10.4318/tjg.2013.0681
Possible transmission risks and genotype distribution of hepatitis C virus infection in Western Turkey
(Turk J Gastroenterol 2013; 24: 349-355)
DOI: 10.4318/tjg.2013.0518
Clinical features of elderly Chinese patients with autoimmune hepatitis
(Turk J Gastroenterol 2013; 24: 489-494)
DOI: 10.4318/tjg.2013.0592
Simple non-invasive markers as a predictor of fibrosis and viral response in chronic hepatitis C patients
(Turk J Gastroenterol 2012; 23: 538-545)
DOI: 10.4318/tjg.2012.0358
Pegylated interferon-based treatment in patients with advanced liver disease due to chronic delta hepatitis
(Turk J Gastroenterol 2012; 23: 560-568)
DOI: 10.4318/tjg.2012.0538
Alpha-1 antitrypsin deficiency in patients with chronic hepatitis
(Turk J Gastroenterol 2012; 23: 569-573)
DOI: 10.4318/tjg.2012.0379
Risk factors for higher anti-HCV positivity in a border city in southern Turkey with unique population characteristics
(Turk J Gastroenterol 2012; 23: 574-579)
DOI: 10.4318/tjg.2012.0554
Molecular characterization of hepatitis A virus isolated from acute infections in Turkey
(Turk J Gastroenterol 2012; 23: 714-719)
DOI: 10.4318/tjg.2012.0450
Prevalence and demographic determinants of gastroesophageal reflux disease (GERD) in the Turkish general population: A population-based cross-sectional study
(Turk J Gastroenterol 2012; 23: 323-332)
DOI: 10.4318/tjg.2012.0352
AST-platelet ratio index in the prediction of significant fibrosis and cirrhosis in patients with chronic hepatitis B
(Turk J Gastroenterol 2012; 23: 353-358)
DOI: 10.4318/tjg.2012.0348
Comparison of the efficacy of tenofovir and entecavir for the treatment of nucleos(t)ide-naive patients with chronic hepatitis B
(Turk J Gastroenterol 2012; 23: 247-252)
DOI: 10.4318/tjg.2012.0380
Serum complement C4 in chronic hepatitis C: Correlation with histopathologic findings and disease activity
(Turk J Gastroenterol 2012; 23: 33-37)
DOI: 10.4318/tjg.2012.0310
Characteristics of patients dying from acute viral hepatitis in Serbia
(Turk J Gastroenterol 2011; 22: 152-157)
DOI: 10.4318/tjg.2011.0184
The impact of hepatitis C virus infection on long-term outcome in renal transplant patients
(Turk J Gastroenterol 2011; 22: 165-170)
DOI: 10.4318/tjg.2011.0236
AST-platelet ratio index, Forns index and FIB-4 in the prediction of significant fibrosis and cirrhosis in patients with chronic hepatitis C
(Turk J Gastroenterol 2011; 22: 279-285)
DOI: 10.4318/tjg.2011.0213
Serum iron parameters in cirrhosis and chronic hepatitis: Detailed description
(Turk J Gastroenterol 2011; 22: 606-611)
DOI: 10.4318/tjg.2011.0323
Ornidazole-induced autoimmune hepatitis
(Turk J Gastroenterol 2011; 22: 494-499)
DOI: 10.4318/tjg.2011.0245
Acute liver failure in Turkey: A systematic review
(Turk J Gastroenterol 2014; 25: 35-40)
DOI: 10.5152/tjg.2014.4231
Drug- and herb-induced liver injury: A case series from a single center
(Turk J Gastroenterol 2014; 25: 41-45)
DOI: 10.5152/tjg.2014.4486
Epidemiological shift of hepatitis A in central Adana, Turkey
(Turk J Gastroenterol 2014; 25: 6-8)
DOI: 10.5152/tjg.2014.4163
Fatty liver disease might increase the risk of abdominal operation in patients with fatty liver and the prevalence of cancer in first-degree relatives
(Turk J Gastroenterol 2014; 25: 138-141)
DOI: 10.5152/tjg.2014.7674
Relation between serum quantitative HBsAg, ALT and HBV DNA levels in HBeAg negative chronic HBV infection
(Turk J Gastroenterol 2014; 25: 142-146)
DOI: 10.5152/tjg.2014.5711
A comparison of the effects of infliximab, adalimumab, and pentoxifylline on rats with non-alcoholic steatohepatitis
(Turk J Gastroenterol 2014; 25: 167-175)
DOI: 10.5152/tjg.2014.5121
The development of a clinical score for the prediction of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease using routine parameters
(Turk J Gastroenterol 2015; 26: 408-416)
DOI: 10.5152/tjg.2015.6336
Gallstones in liver transplant recipients: A single-center study in China
(Turk J Gastroenterol 2015; 26: 429-434)
DOI: 10.5152/tjg.2014.6344
A systematic review of the prevalence and risk factors of irritable bowel syndrome among medical students
(Turk J Gastroenterol 2016; 27: 10-16)
DOI: 10.5152/tjg.2015.150333
Prevalence of Barrett's esophagus in Lebanon
(Turk J Gastroenterol 2015; 26: 214-217)
DOI: 10.5152/tjg.2015.0135
Ten-year analysis of hepatitis-related papers in the Middle East: a web of science-based scientometric study
(Turk J Gastroenterol 2017; 28: 20-25)
DOI: 10.5152/tjg.2016.0572
Decreasing prevalence of Helicobacter pylori according to birth cohorts in urban China
(Turk J Gastroenterol 2017; 28: 94-97)
DOI: 10.5152/tjg.2017.16557
Responsiveness of children with celiac disease to different hepatitis B vaccination protocols
(Turk J Gastroenterol 2011; 22: 27-31)
DOI: 10.4318/tjg.2011.0152
A comparative study of celiac disease in children with migraine headache and a normal control group
(Turk J Gastroenterol 2011; 22: 32-35)
DOI: 10.4318/tjg.2011.0153
Promotional effect of nonalcoholic fatty liver disease on Gallstone disease: A systematic review and meta-analysis
(Turk J Gastroenterol 2017; 28: 31-39)
DOI: 10.5152/tjg.2016.0357
Prevalence of celiac disease among the Iranian population: A systematic review and meta-analysis of observational studies
(Turk J Gastroenterol 2016; 27: 122-128)
DOI: 10.5152/tjg.2015.150191
Impact of fatty liver on hepatitis B virus replication and virologic response to tenofovir and entecavir
(Turk J Gastroenterol 2016; 27: 42-46)
DOI: 10.5152/tjg.2015.150348
Role of Th1/Th2 cells and related cytokines in autoimmune hepatitis
(Turk J Gastroenterol 2017; 28: 110-114)
DOI: 10.5152/tjg.2017.17501
Relations between human leukocyte antigens and autoimmune hepatitis in Turkish children
(Turk J Gastroenterol 2011; 22: 42-46)
DOI: 10.4318/tjg.2011.0155
The importance of the serum quantitative levels of hepatitis B surface antigen and hepatitis B e antigen in children with chronic hepatitis B
(Turk J Gastroenterol 2015; 26: 36-41)
DOI: 10.5152/tjg.2015.4636
Is there any relationship between unrecognized Celiac disease and unexplained infertile couples?
(Turk J Gastroenterol 2015; 26: 484-486)
DOI: 10.5152/tjg.2015.0123
Can eicosapentaenoic acid maintain the original ribavirin dose or affect the response during the treatment course of chronic hepatitis C virus (HCV) patients?
(Turk J Gastroenterol 2016; 27: 55-61)
DOI: 10.5152/tjg.2015.150280
Hepatitis C virus genotype distribution in Turkey remains unchanged after a decade: Performance of phylogenetic analysis of the NS5B, E1, and 5’UTR regions in genotyping efficiency
(Turk J Gastroenterol 2014; 25: 405-410)
DOI: 10.5152/tjg.2014.7083
Routinely evaluated clinical assays and laboratory tests [real test] and fibrosis stages of chronic hepatitis B and C
(Turk J Gastroenterol 2014; 25: 539-545)
DOI: 10.5152/tjg.2014.6170
The predictive value of noninvasive serum markers of liver fibrosis in patients with chronic hepatitis C
(Turk J Gastroenterol 2016; 27: 156-164)
DOI: 10.5152/tjg.2015.150449
Effect of SIRS and sepsis on mortality in alcoholic hepatitis: A systematic review and meta-analysis
(Turk J Gastroenterol 2016; 27: 458-463)
DOI: 10.5152/tjg.2016.16188
Can the Abbott RealTime hepatitis C virus assay be used to predict therapeutic outcomes in hepatitis C virus-infected patients undergoing triple therapy?
(Turk J Gastroenterol 2016; 27: 165-172)
DOI: 10.5152/tjg.2016.150300
The association between insulin resistance and hepatic fibrosis in patients with chronic hepatitis C: An observational, multicenter study in Turkey
(Turk J Gastroenterol 2014; 25: 546-552)
DOI: 10.5152/tjg.2014.7829
The relation between liver histopathology and GGT levels in viral hepatitis: More important in hepatitis B
(Turk J Gastroenterol 2014; 25: 411-415)
DOI: 10.5152/tjg.2014.3693
Public awareness of hepatitis B infection in Turkey as a model of universal effectiveness in health care policy
(Turk J Gastroenterol 2014; 25: 304-308)
DOI: 10.5152/tjg.2014.6718
The role of diet in the overlap between gastroesophageal reflux disease and functional dyspepsia
(Turk J Gastroenterol 2016; 27: 73-80)
DOI: 10.5152/tjg.2015.150238
Evaluation of fluvastatin in combination with the standard of care therapy (PEG-IFN/Ribavirin) in Egyptian patients with hepatitis C virus
(Turk J Gastroenterol 2015; 26: 511-516)
DOI: 10.5152/tjg.2015.15806
Five-year results of oral antiviral therapy in HBeAg-negative chronic Hepatitis B
(Turk J Gastroenterol 2016; 27: 279-283)
DOI: 10.5152/tjg.2016.16085
Effects of mannose-binding lectin and mannose-binding lectin polymorphisms on treatment response in patients with chronic hepatitis C
(Turk J Gastroenterol 2014; 25: 702-706)
DOI: 10.5152/tjg.2014.6583
Quick Look to Guidelines
Management of special patient groups with hepatitis B virus infection: The EASL 2017 Clinical Practice Guidelines
(Turk J Gastroenterol 2017; 28: 518-521)
DOI: 10.5152/tjg.2017.171017
Gastrointestinal Tract - Original Article
Non-alcoholic fatty liver disease: A growing public health problem in Turkey
(Turk J Gastroenterol ; : -)
DOI: 10.5152/tjg.2019.18045
Liver - Original Article
Seroprevalence of hepatitis B, hepatitis C, and HIV in pregnant women from Eastern Turkey
(Turk J Gastroenterol 2019; 30: 260-265)
DOI: 10.5152/tjg.2018.17634
Screening for hepatic fibrosis and steatosis in Turkish patients with type 2 diabetes mellitus: A transient elastography study
(Turk J Gastroenterol 2019; 30: 266-270)
DOI: 10.5152/tjg.2018.18559
Real-life results of treatment with ombitasvir, paritaprevir, dasabuvir, and ritonavir combination in patients with chronic renal failure infected with HCV in Turkey
(Turk J Gastroenterol 2019; 30: 331-335)
DOI: 10.5152/tjg.2018.18269
Growing burden of nonalcoholic fatty liver disease in Turkey: A single-center experience
(Turk J Gastroenterol ; : -)
DOI: 10.5152/tjg.2019.19072
Reactivation rates in patients using biological agents, with resolved HBV infection or isolated anti-HBc IgG positivity
(Turk J Gastroenterol 2018; 29: 561-565)
DOI: 10.5152/tjg.2018.18032
Assessing the outcome of patients with liver cirrhosis during hospital stay: A comparison of lymphocyte/monocyte ratio with MELD and Child-Pugh scores
(Turk J Gastroenterol 2018; 29: 308-315)
DOI: 10.5152/tjg.2018.17631
Insulin/high-density lipoprotein cholesterol ratio: A newly-discovered predictor of esophageal varices in patients with hepatitis C virus-related cirrhosis in the absence of diabetes mellitus
(Turk J Gastroenterol 2019; 30: 155-162)
DOI: 10.5152/tjg.2018.18237
Determination of certain bacterial groups in gut microbiota and endotoxin levels in patients with nonalcoholic steatohepatitis
(Turk J Gastroenterol 2017; 28: 361-369)
DOI: 10.5152/tjg.2017.17033
Does steatosis affect the performance of diffusion-weighted MRI values for fibrosis evaluation in patients with chronic hepatitis C genotype 4?
(Turk J Gastroenterol 2017; 28: 283-288)
DOI: 10.5152/tjg.2017.16640
Lamivudine’s efficacy and safety in preventing mother-to-child transmission of hepatitis B: A meta-analysis
(Turk J Gastroenterol 2019; 30: 66-74)
DOI: 10.5152/tjg.2018.18148
Role of nucleoside/nucleotide analogues and low-dose hepatitis B immune globulin in prophylaxis of hepatitis B recurrence among cadaveric liver transplant recipients
(Turk J Gastroenterol 2018; 29: 61-66)
DOI: 10.5152/tjg.2018.17595
Diagnostic value of combined serum biomarkers for the evaluation of liver fibrosis in chronic hepatitis C infection: A multicenter, noninterventional, observational study
(Turk J Gastroenterol 2018; 29: 464-472)
DOI: 10.5152/tjg.2018.16597
Pediatric Gastroenterology - Original Article
Helicobacter pylori prevalence and risk factors among children with celiac disease
(Turk J Gastroenterol 2019; 30: 284-289)
DOI: 10.5152/tjg.2018.18181
Pancreatobiliary - Original Article
Do bad habits bring a double constipation risk?
(Turk J Gastroenterol 2018; 29: 580-587)
DOI: 10.5152/tjg.2018.17533
Do bad habits bring a double constipation risk?
(Turk J Gastroenterol ; : -)
DOI: 10.5152/tjg.2018.17533
Poster
Real-world efficacy, safety and clinical outcomes of ombitasvir/ paritaprevir/ ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: Turkey experience
(Turk J Gastroenterol 2019; 30: 10-15)
DOI: 10.5152/tjg.2019.07
Nonsirotic chronic hepatitis B presenting with hepatocellular carcinoma: a case report
(Turk J Gastroenterol 2019; 30: 16-17)
DOI: 10.5152/tjg.2019.08
Retrospective Investigation of De novo hepatitis B infection in recipients after liver transplantation by anti-HBc positive donors
(Turk J Gastroenterol 2019; 30: 20-20)
DOI: 10.5152/tjg.2019.10
A case of acute toxic hepatitis associated with Prangos ferulacea
(Turk J Gastroenterol 2019; 30: 23-23)
DOI: 10.5152/tjg.2019.12
Evaluation of rheumatologists’ awareness of hepatitis B reactivation before immunosuppressive treatment
(Turk J Gastroenterol 2019; 30: 25-25)
DOI: 10.5152/tjg.2019.14
From cirrhosis to hepatocellular carcinoma: An investigation into hepatitis C viral oncogenesis using meta-analysis
(Turk J Gastroenterol 2019; 30: 26-28)
DOI: 10.5152/tjg.2019.15
Letrozole-induced hepatitis in 42-year-old woman with invasive ductal breast cancer
(Turk J Gastroenterol 2019; 30: 30-30)
DOI: 10.5152/tjg.2019.17
Successfully treatment of chronic hepatitis C with direct-acting antiviral agents: a single center experience
(Turk J Gastroenterol 2019; 30: 34-34)
DOI: 10.5152/tjg.2019.20
Efficacy of entecavir treatment for up to 5 years in patients with HBV-related compensated cirrhosis in Turkey; real life data
(Turk J Gastroenterol 2019; 30: 36-36)
DOI: 10.5152/tjg.2019.22
A rare case of hepatitis: Giant cell hepatitis
(Turk J Gastroenterol 2019; 30: 37-37)
DOI: 10.5152/tjg.2019.23
Hepatitis b reactivation rate in patients using anti tnf theraphy: Evaluation of patients not received anti viral prophylaxis
(Turk J Gastroenterol 2019; 30: 38-38)
DOI: 10.5152/tjg.2019.24
A real-life evaluation of the effect of direct-acting antivirals in hemodialysis patients with chronic hepatitis C
(Turk J Gastroenterol 2019; 30: 39-40)
DOI: 10.5152/tjg.2019.25
Prevalence of the potential drug-drug interactions between pangenotypic direct-acting antivirals and the concomitant medication with patients with chronic hepatitis C virus infection
(Turk J Gastroenterol 2019; 30: 43-45)
DOI: 10.5152/tjg.2019.28
Toxic hepatitis and hyponatremia: Case report
(Turk J Gastroenterol 2019; 30: 51-52)
DOI: 10.5152/tjg.2019.33
Evaluation of 24-year followig results of patients with inactive hepatitis B
(Turk J Gastroenterol 2019; 30: 55-55)
DOI: 10.5152/tjg.2019.35
Case Report: Drug-induced liver injury mimicking hypereosinophilic syndrome
(Turk J Gastroenterol 2019; 30: 63-63)
DOI: 10.5152/tjg.2019.40
Clinical characteristics of hepatocellular carcinoma: Results from central Anatolian region of Turkey
(Turk J Gastroenterol 2019; 30: 65-65)
DOI: 10.5152/tjg.2019.42
Liver biopsy may not be the optimal option for assessing treatment efficacy in chronic hepatitis delta (CHD) infection
(Turk J Gastroenterol 2019; 30: 67-67)
DOI: 10.5152/tjg.2019.44
Direct-acting antiviral drugs used ın the treatment of HCV Increase cholesterol levels
(Turk J Gastroenterol 2019; 30: 69-69)
DOI: 10.5152/tjg.2019.46
A case with chronic HBV infection who was non-responder to nucleos(t)ide analogues was treated with Pegylated interferon
(Turk J Gastroenterol 2019; 30: 70-72)
DOI: 10.5152/tjg.2019.47
Prospective and Randomized Comparison of Tenofovir and Entecavir in Hepatitis B Reactivation Prophylaxis in Patients Receiving Immunosuppressive Therapy
(Turk J Gastroenterol 2019; 30: 73-73)
DOI: 10.5152/tjg.2019.48
Clinical and laboratory features of children with chronic hepatitis B infection: A single center results
(Turk J Gastroenterol 2019; 30: 74-74)
DOI: 10.5152/tjg.2019.49
Acute liver ınjury in a patient with secondary syphilis and acute viral hepatitis B coinfection
(Turk J Gastroenterol 2019; 30: 75-75)
DOI: 10.5152/tjg.2019.50
Effect of sofosbuvir on QT interval and other electrocardiography (ECG) findings in patients with HCV related decompase cirrhosis
(Turk J Gastroenterol 2019; 30: 76-76)
DOI: 10.5152/tjg.2019.51
Investigation of the factors affecting the response of treatment ın patients treated with oral direct acting antiviral agents
(Turk J Gastroenterol 2019; 30: 79-80)
DOI: 10.5152/tjg.2019.53
Clinical outcomes after cessation of potent antiviral treatment in chronic hepatitis B patients
(Turk J Gastroenterol 2019; 30: 81-82)
DOI: 10.5152/tjg.2019.54
Awareness of hepatitis C
(Turk J Gastroenterol 2019; 30: 85-85)
DOI: 10.5152/tjg.2019.56
Diagnosis ways of chronic HBV cases
(Turk J Gastroenterol 2019; 30: 86-86)
DOI: 10.5152/tjg.2019.57
Thyroid manifestations in autoimmune liver diseases: a single center experience
(Turk J Gastroenterol 2019; 30: 89-90)
DOI: 10.5152/tjg.2019.59
Primary immune deficiency screening in patients with biopsy proven autoimmune liver diseases
(Turk J Gastroenterol 2019; 30: 91-91)
DOI: 10.5152/tjg.2019.60
Comparison of antivirals in prophylaxis of HBV reactivation in patients receiving immunsuppressive therapy
(Turk J Gastroenterol 2019; 30: 92-92)
DOI: 10.5152/tjg.2019.61
Poster Presentation
Evaluation of diagnostic performance simple non-invasıve fibrosis markers in patients with chronic hepatitis B
(Turk J Gastroenterol 2019; 30: 100-100)
DOI: 10.5152/tjg.2019.65
The evaluation of liver biopsy specimens of chronic hepatitis B patients using early tissue markers for Hepatocellular Carcinoma: Before and after the development of Hepatocellular Carcinoma
(Turk J Gastroenterol 2019; 30: 102-102)
DOI: 10.5152/tjg.2019.67
Changing in the etiologies and the presentation charactheristics in hepatocellular carcinoma. A single center experience in western Turkey
(Turk J Gastroenterol 2019; 30: 103-105)
DOI: 10.5152/tjg.2019.68
Key Words
Authors
All
Reviewer's Corner
Author’s Corner
Survey
AVES | Copyright © 2019 Turkish Society of Gastroenterology | Latest Update: 04.07.2019